MARKET

SESN

Sesen Bio, Inc.
SESN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.6308
22.32
4.166
127,955,896.62
BUZZ-U.S. STOCKS ON THE MOVE-Venture Global, TSMC, Oracle
Reuters · 10/10 16:09
Carisma Therapeutics to Be Delisted from Nasdaq Will Trade on OTCID Amid Regulatory Noncompliance
Reuters · 10/09 21:12
Carisma Therapeutics Chief Scientific Officer Michael Klichinsky Reports Disposal of Common Shares
Reuters · 10/08 20:17
Carisma Therapeutics Chief Scientific Officer Michael Klichinsky Reports Disposal of Common Shares
Reuters · 10/03 21:25
Ocugen Inc. Announces Termination of Merger Agreement with Carisma Therapeutics Due to Funding Shortfall
Reuters · 09/18 15:01
Carisma Therapeutics Amends Agreement with Moderna, Receives $4 Million Payment
Reuters · 09/18 13:15
Ocugen Inc. Finalizes Merger Agreement with Carisma Therapeutics, Inc., Including a $5 Million Investment in Common Stock
Reuters · 09/05 20:12
Carisma Therapeutics Inc. Announces $5 Million Share Purchase Agreement with Ocugen in Private Placement
Reuters · 08/29 20:21
More

Webull offers Sesen Bio, Inc. stock information, including NASDAQ: SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SESN stock methods without spending real money on the virtual paper trading platform.